Aegon Ltd Dossier
Financial Snapshot
Revenue, profitability, returns, debt, and capital allocation
Free Cash Flow $461.7MTTM through 31 Dec 2025
Margins
| Current | |
|---|---|
| Operating Margin | 18.7% |
| Net Margin | 4.6% |
Returns
10.3%ROE
0.3%ROA
Balance Sheet Health
Debt / Equity0.55x
Net Debt$2.5B
Cash & Equivalents$2.7B
Quality Metrics
Piotroski F-Score4 / 9
FCF Margin1.8%
Multi-Year Trend
RevenueFY2022: $21.3B
Diluted EPSFY2025: $0.63
Dividend
2.76%Yield1 yrsStreak+8.3%5-yr growth
Capital Allocation
Capex Intensity0.2%
Segment Performance
| Segment | Revenue | YoY | Outlook |
|---|---|---|---|
| Americas Strategic Assets | View detailsCommercial momentum remains strong in the US, with WFG expanding its distribution network and new life sales growing. | ||
| Americas Financial Assets | View detailsRun-off of Financial Assets continues to reduce capital employed towards targets. |
Financials converted at 0.8513 from EUR.
Filing Detail Members
This section is available to registered members. Create a free account or sign in to unlock the full breakdown.